Marija Stojanova

Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins

J. Wisco, C. Heaphy, G. Denis, 2022, The Prostate.

Therapeutic vulnerability to ATR inhibition in concurrent NF1 and ATRX-deficient high-grade solid tumors

Karlyne M. Reilly, K. Reilly, C. Pratilas, 2022, bioRxiv.

Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors

Karlyne M. Reilly, K. Reilly, C. Pratilas, 2022, Cancers.

Predicting recurrence in pancreatic neuroendocrine tumours: role of ARX and alternative lengthening of telomeres (ALT)

V. Deshpande, Deepa T. Patil, C. Heaphy, 2023, Histopathology.